Home > Healthcare > Medical Devices > Therapeutic Devices > Robotic Endoscopy Devices Market
Robotic Endoscopy Devices Market Size
Robotic Endoscopy Devices Market size was valued at around USD 2.4 billion in 2023 and is estimated to expand at 11% CAGR from 2024 to 2032, owing to the rising prevalence of gastrointestinal disorders and other chronic ailments, coupled with surging demand for minimally invasive procedures.
The increasing incidence of gastrointestinal disorders and other chronic illnesses, such as ulcerative colitis, irritable bowel syndrome, chronic constipation, diverticular disease, gallstones, and hemorrhoids, among others, is one of the prime factors driving the demand for robotic endoscopic devices. The rise in gastrointestinal diseases is due to various factors, including increased antibiotic usage, poor dietary choices, sedentary lifestyle, exposure to environmental toxins, and the growing proportion of aging demographics.
For instance, according to a study published in the Gastroenterology journal in 2020, functional gastrointestinal disorders (FGIDs) exhibit a substantial global prevalence, affecting approximately 40% of the general populace with at least one FGID. Additionally, the as per the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) conducted in 2019, states that digestive diseases constituted 2.3 billion estimated prevalent cases, resulting in 2.56 million deaths and 89 million DALYs (Disability-Adjusted Life Years) worldwide.
Robotic endoscopic devices are advanced medical instruments equipped with robotic technology that assist in performing endoscopic procedures. These devices are designed to enhance precision, control, and maneuverability during endoscopic examinations and interventions within the body's cavities and organs.
Report Attributes | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 2.4 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 11% |
2032 Value Projection: | USD 6.2 Billion |
Historical Data for: | 2018 - 2023 |
No. of Pages: | 110 |
Tables, Charts & Figures: | 206 |
Segments covered: | Product Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Robotic Endoscopy Devices Market Trends
The increasing technological adaptability of robotic endoscopy devices is predicted to propel their rising demand globally. The robotic technology enables numerous advancements in the devices and rapid utilization of such developments in the surgical procedures, thereby, increasing the products demand.
- Technological advancements have facilitated the integration of robotic technology into different endoscopy devices, such as flexible and rigid endoscopes. The rigid endoscopy devices combine an endoscope with a robot to hold the endoscope steadily throughout procedures, ensuring a consistent view of the surgical field without fatigue or tremors.
- Additionally, innovations such as the EndoDrive system for robot-assisted flexible endoscopy provide electro-mechanical support for shaft insertion and incorporate features including foot pedals, freeing up the physician's hands for maneuvering and focusing solely on the procedure. These advancements have significantly driven the demand for robotic endoscopy devices.
- Robotic endoscopy systems have also witnessed significant advancements through the integration of advanced imaging technology, ergonomic design, and improved maneuverability. These developments aim to enhance visual fields, distal dexterity, particularly during complex procedures such as endoscopic submucosal dissection (ESD).
- An example of such innovation is the Endoscopic Operation Robot, developed by the Kyushu Institute of Technology in Kitakyushu, Japan. This system can be attached to a conventional scope, offering nine degrees of freedom and enabling two endoscopists to manipulate the device simultaneously. These cutting-edge features are anticipated to drive the demand for surgical procedures, consequently boosting the market for robotic endoscopy devices.
Robotic Endoscopy Devices Market Analysis
Based on product type, the market is segmented into diagnostic and therapeutic. The therapeutic segment held dominating revenue share in 2023 and is anticipated to reach USD 5.9 billion by 2032.
- The therapeutic segment growth is primarily driven by the surging demand for minimally invasive procedures worldwide. Robotic endoscopic interventions, characterized by their minimally invasive nature, offer numerous advantages to patients over traditional surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications.
- Additionally, the utilization of robotic endoscopy devices to conduct diverse interventions aimed at treating or managing range of medical conditions. These interventions encompass a spectrum of procedures such as polyp removal, hemostasis, stricture dilation, tumor treatment, targeted therapy delivery, among others. Consequently, these devices play a crucial role in addressing an extensive array of gastrointestinal and other medical issues, resulting in the segment growth.
Based on applications, the robotic endoscopy devices market is segmented into colonoscopy, bronchoscopy, laparoscopy, gastroscopy, and other applications. The laparoscopy segment held leading revenue share and was valued at over USD 1.6 billion in 2023.
- The high procedural volume of laparoscopy segment is primarily attributed to the minimally invasive nature of laparoscopic procedures. These techniques entail small incisions instead of larger ones as necessitated by traditional open surgeries.
- Additionally, the advantages offered by laparoscopic procedures contribute to their cost-effectiveness. Despite the initial higher investment in robotic systems compared to traditional laparoscopic equipment, studies have demonstrated that robotic-assisted laparoscopic surgeries can result in long-term cost savings. This is attributed to factors such as reduced hospital stays, fewer complications, and quicker patient recovery times.
The robotic endoscopy devices market by end-use is categorized into hospitals, ambulatory surgical centers, and other end users. The hospital segment dominates the market accounting for around USD 1.5 billion in 2023.
- Hospitals, with their robust infrastructure and resources, are equipped to offer comprehensive training and support to surgeons and staff for the proficient operation of robotic endoscopy devices. This commitment ensures that healthcare professionals can utilize the equipment effectively, ultimately leading to increased utilization of the endoscopy devices in the hospital settings.
- Moreover, hospitals typically have a large volume of patients including aging population requiring surgical interventions and other complex procedures. Robotic endoscopy devices can help hospitals meet the demand for complex surgical procedures while maintaining high standards of patient care and safety, propelling the segment landscape.
North America robotic endoscopy devices market accounted for around USD 1.5 billion revenue in 2023 and is predicted to witness substantial market growth.
- The prevalence of obesity and diabetes has been on the rise in North America, particularly in the U.S., where obesity has a significant target population. This increasing trend is closely associated with elevated risk factors including poor dietary habits, sedentary lifestyles, and other factors. These factors contributes to the increasing prevalence of gastrointestinal and urology disorders in turn fueling the demand for robotic endoscopy devices in the region.
- Furthermore, the increase in aging population is substantially propelling the market progress. As individuals age, they become more susceptible to age-related diseases such as colorectal cancer, gastrointestinal bleeding, and diverticulosis. Robotic endoscopy devices offer advanced diagnostic and therapeutic capabilities, allowing for more accurate detection and treatment of these conditions in elderly patients, resulting in increased number of patients seeking the treatment.
Robotic Endoscopy Devices Market Share
The robotic endoscopy devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Intuitive Surgical, Olympus Corporation, Boston Scientific Corporation, Brainlab AG and CONMED Corporation among others have a notable presence in the market.
Robotic Endoscopy Devices Market Companies
Some of the eminent market participants operating in the robotic endoscopy devices industry include:
- AKTORmed GmbH
- Asensus Surgical Inc.
- Boston Scientific Corporation
- Brainlab AG
- CONMED Corporation
- FUJIFILM Holdings Corporation
- Intuitive Surgical, Inc.
- Karl Storz SE & Co. KG
- Medtronic plc
- Olympus Corporation
- Renishaw plc
- Richard Wolf GmbH
Robotic Endoscopy Devices Industry News:
- In January 2023, Fujifilm expanded its endoscopy solutions portfolio for therapeutic gastrointestinal applications. This expansion may help the company to enhance its market positioning and generate greater revenue in coming years.
- In December 2022, Medtronic announced the enrollment of the first patient in the Expand URO U.S. clinical trial for the Hugo robotic-assisted surgery (RAS) system, which is intended to be used for urologic surgical procedures including radical prostatectomy, radical cystectomy, and nephrectomy procedures at sites in the country. This initiative may improve the company’s positioning in the robotic endoscopy device market and enable more customer base.
Robotic endoscopy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product Type
- Diagnostic
- Therapeutic
Market, By Application
- Colonoscopy
- Bronchoscopy
- Laparoscopy
- Gastroscopy
- Other applications
Market, By End-use
- Hospitals
- Ambulatory surgical centers
- Other end-users
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East and Africa
Frequently Asked Questions (FAQ) :